List of bibliographic references
Number of relevant bibliographic references: 15.
| Ident. | Authors (with country if any) | Title |
|---|
| 000E64 (2017) |
Ruth Ladenstein ; Ulrike Pötschger ; Andrew D J. Pearson ; Penelope Brock ; Roberto Luksch ; Victoria Castel ; Isaac Yaniv ; Vassilios Papadakis ; Geneviève Laureys ; Josef Malis ; Walentyna Balwierz ; Ellen Ruud ; Per Kogner ; Henrik Schroeder ; Ana Forjaz De Lacerda ; Maja Beck-Popovic ; Pavel Bician ; Mikl S Garami ; Toby Trahair ; Adela Canete ; Peter F. Ambros ; Keith Holmes ; Mark Gaze ; Günter Schreier ; Alberto Garaventa ; Gilles Vassal ; Jean Michon ; Dominique Valteau-Couanet | Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial. |
| 001095 (2017) |
Nathan Touati ; Konstantinos Tryfonidis ; Franco Caramia ; Hervé Bonnefoi ; David Cameron ; Leen Slaets ; Belinda S. Parker ; Sherene Loi | Correlation between severe infection and breast cancer metastases in the EORTC 10994/BIG 1-00 trial: Investigating innate immunity as a tumour suppressor in breast cancer. |
| 001237 (2017) |
Tomasz M. Beer ; Eugene D. Kwon ; Charles G. Drake ; Karim Fizazi ; Christopher Logothetis ; Gwenaelle Gravis ; Vinod Ganju ; Jonathan Polikoff ; Fred Saad ; Piotr Humanski ; Josep M. Piulats ; Pablo Gonzalez Mella ; Siobhan S. Ng ; Dirk Jaeger ; Francis X. Parnis ; Fabio A. Franke ; Javier Puente ; Roman Carvajal ; Lisa Sengel V ; M Brent Mchenry ; Arvind Varma ; Alfonsus J. Van Den Eertwegh ; Winald Gerritsen | Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer. |
| 001F48 (2016) |
Susan Halabi ; William Kevin Kelly ; Hua Ma ; Haojin Zhou ; Nicole C. Solomon ; Karim Fizazi ; Catherine M. Tangen ; Mark Rosenthal ; Daniel P. Petrylak ; Maha Hussain ; Nicholas J. Vogelzang ; Ian M. Thompson ; Kim N. Chi ; Johann De Bono ; Andrew J. Armstrong ; Mario A. Eisenberger ; Abderrahim Fandi ; Shaoyi Li ; John C. Araujo ; Christopher J. Logothetis ; David I. Quinn ; Michael J. Morris ; Celestia S. Higano ; Ian F. Tannock ; Eric J. Small | Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer. |
| 002393 (2016) |
A. Lipton ; K. Fizazi ; A T Stopeck ; D H Henry ; M R Smith ; N. Shore ; M. Martin ; S. Vadhan-Raj ; J E Brown ; G E Richardson ; F. Saad ; D A Yardley ; K. Zhou ; A. Balakumaran ; A. Braun | Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics. |
| 002488 (2016) |
N. Raje ; S. Vadhan-Raj ; W. Willenbacher ; E. Terpos ; V. Hungria ; A. Spencer ; Y. Alexeeva ; T. Facon ; A K Stewart ; A. Feng ; A. Braun ; A. Balakumaran ; G D Roodman | Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial. |
| 002838 (2015) |
R. Libé ; I. Borget ; C L Ronchi ; B. Zaggia ; M. Kroiss ; T. Kerkhofs ; J. Bertherat ; M. Volante ; M. Quinkler ; O. Chabre ; M. Bala ; A. Tabarin ; F. Beuschlein ; D. Vezzosi ; T. Deutschbein ; F. Borson-Chazot ; I. Hermsen ; A. Stell ; C. Fottner ; S. Leboulleux ; S. Hahner ; M. Mannelli ; A. Berruti ; H. Haak ; M. Terzolo ; M. Fassnacht ; E. Baudin | Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. |
| 002913 (2015) |
Fred Saad ; Neal Shore ; Hendrik Van Poppel ; Dana E. Rathkopf ; Matthew R. Smith ; Johann S. De Bono ; Christopher J. Logothetis ; Paul De Souza ; Karim Fizazi ; Peter F A. Mulders ; Paul Mainwaring ; John D. Hainsworth ; Tomasz M. Beer ; Scott North ; Yves Fradet ; Thomas A. Griffin ; Peter De Porre ; Anil Londhe ; Thian Kheoh ; Eric J. Small ; Howard I. Scher ; Arturo Molina ; Charles J. Ryan | Impact of bone-targeted therapies in chemotherapy-naïve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: post hoc analysis of study COU-AA-302. |
| 002962 (2015) |
Jean-Jacques Body ; Henry G. Bone ; Richard H. De Boer ; Alison Stopeck ; Catherine Van Poznak ; Ronaldo Damião ; Karim Fizazi ; David H. Henry ; Toni Ibrahim ; Allan Lipton ; Fred Saad ; Neal Shore ; Toshimi Takano ; Adam J. Shaywitz ; Huei Wang ; Oswaldo L. Bracco ; Ada Braun ; Paul J. Kostenuik | Hypocalcaemia in patients with metastatic bone disease treated with denosumab. |
| 002B67 (2015) |
Ingo J. Diel ; Jean-Jacques Body ; Alison T. Stopeck ; Saroj Vadhan-Raj ; Andrew Spencer ; Günther Steger ; Roger Von Moos ; François Goldwasser ; Amy Feng ; Ada Braun | The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease. |
| 002E57 (2015) |
Michael J. Morris ; Arturo Molina ; Eric J. Small ; Johann S. De Bono ; Christopher J. Logothetis ; Karim Fizazi ; Paul De Souza ; Philip W. Kantoff ; Celestia S. Higano ; Jinhui Li ; Thian Kheoh ; Steven M. Larson ; Shannon L. Matheny ; Vahid Naini ; Tomasz Burzykowski ; Thomas W. Griffin ; Howard I. Scher ; Charles J. Ryan | Radiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 results. |
| 002E97 (2015) |
R J Van Soest ; A J Templeton ; F E Vera-Badillo ; F. Mercier ; G. Sonpavde ; E. Amir ; B. Tombal ; M. Rosenthal ; M A Eisenberger ; I F Tannock ; R. De Wit | Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials. |
| 003009 (2015) |
Charles J. Ryan ; Matthew R. Smith ; Karim Fizazi ; Fred Saad ; Peter F A. Mulders ; Cora N. Sternberg ; Kurt Miller ; Christopher J. Logothetis ; Neal D. Shore ; Eric J. Small ; Joan Carles ; Thomas W. Flaig ; Mary-Ellen Taplin ; Celestia S. Higano ; Paul De Souza ; Johann S. De Bono ; Thomas W. Griffin ; Peter De Porre ; Margaret K. Yu ; Youn C. Park ; Jinhui Li ; Thian Kheoh ; Vahid Naini ; Arturo Molina ; Dana E. Rathkopf | Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study. |
| 003028 (2015) |
M R Smith ; R E Coleman ; L. Klotz ; K. Pittman ; P. Milecki ; S. Ng ; K N Chi ; A. Balakumaran ; R. Wei ; H. Wang ; A. Braun ; K. Fizazi | Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events. |
| 003B13 (2013) |
Matthew R. Smith ; Fred Saad ; Stephane Oudard ; Neal Shore ; Karim Fizazi ; Paul Sieber ; Bertrand Tombal ; Ronaldo Damiao ; Gavin Marx ; Kurt Miller ; Peter Van Veldhuizen ; Juan Morote ; Zhishen Ye ; Roger Dansey ; Carsten Goessl | Denosumab and bone metastasis-free survival in men with nonmetastatic castration-resistant prostate cancer: exploratory analyses by baseline prostate-specific antigen doubling time. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Bone Neoplasms"
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i \
-Sk "Bone Neoplasms" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= indexItem
|index= MedMesh.i
|clé= Bone Neoplasms
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 |  |
